Dr. Jonathan Goodman is desperate to cure his son Daniel's cancer. His wife, Lilith, becomes pregnant with another child, a sibling whose DNA can potentially cure Daniel. Their hopes are dashed when a genetic disorder is detected in their unborn child. When Daniel dies and their unborn child miscarries, grief and devastation splinter the couple's bond. Under emotional duress but driven to honor Daniel's memory, Jonathan, a brilliant medical researcher, makes a major breakthrough using genetically modified laboratory mice. He develops a novel treatment for several disease clusters, including cancer. Bypassing all protocols to push his findings forward, Goodman unethically secures approval and funding for a human clinical trial. With enough funding for four participants, Goodman carefully chooses those upon whom he'll experiment. Each participant faces a terminal illness, and Dr. Goodman's exploratory treatment is their last hope for survival. Despite his noble intentions, Goodman is motivated to exorcise the demons that haunt him. Those spirits, however, also besiege each member of the clinical trial. Lives will be forever changed-and possibly lost. Saving those whom Goodman has put in harm's way and saving what is left of his family and career presents an almost insurmountable challenge.